YOUR LENTIVIRUS
SPECIALIZED PARTNER
Lentiviral vectors for gene therapy
DEVELOPMENT AND MANUFACTURING
GMP-SOLUTIONS CDMO
Our main aim is to adapt to your own requirements from a technical and timeline perspective
TECHNOLOGY
OWN TECHNOLOGY DEVELOPMENT
Our main aim is to implement a technology development strategy focused on providing a response to the main hurdles that currently exist within the gene therapy field
LATEST NEWS
05 December 2018
The Chief Scientific/Technology Officer of VIVEbiotech, Juan Carlos Ramírez, participates in a symposium on gene therapy at the UAM
23 November 2018
VIVEbiotech receives the Technological Innovation SME Award granted by Expansión and Ifema
CONTACT OUR EXPERTS FOR FURTHER DISCUSSION
